{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:13:50Z","timestamp":1783512830545,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.schres.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:06:23Z","timestamp":1778756783000},"page":"198-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A systematic review on the effects of clozapine on B-lymphocytes and immunoglobulins"],"prefix":"10.1016","volume":"294","author":[{"given":"Jonathan T.","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian M.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"De Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.05.005_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fimmu.2020.00105","article-title":"Inflammation as a modulator of host susceptibility to pulmonary influenza, pneumococcal, and co-infections","volume":"11","author":"Aguilera","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.schres.2026.05.005_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00406-023-01729-0","article-title":"Vaccination and clozapine use: A systematic review and an analysis of the VAERS database","volume":"275","author":"Aksar","year":"2025","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.05.005_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110449","article-title":"Clozapine reduces chemokine-mediated migration of lymphocytes by targeting NF-\u03baB and AKT phosphorylation","volume":"99","author":"Al Abadey","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.schres.2026.05.005_bb0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clim.2006.05.003","article-title":"Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency","volume":"120","author":"Alachkar","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.schres.2026.05.005_bb0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1192\/bjp.bp.113.142216","article-title":"Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis","volume":"206","author":"Beck","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/7854_2019_93","article-title":"Role of infection, autoimmunity, atopic disorders, and the immune system in schizophrenia: evidence from epidemiological and genetic studies","volume":"44","author":"Benros","year":"2020","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.schres.2026.05.005_bb0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-3223(90)90467-G","article-title":"Neuroleptic-associated autoantibodies: A prevalence study","volume":"27","author":"Canoso","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2023.152370","article-title":"Association between autoimmune diseases of the nervous system and schizophrenia: A systematic review and meta-analysis of cohort studies","volume":"122","author":"Cao","year":"2023","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2004.10.048","article-title":"The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency","volume":"115","author":"Carsetti","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.schres.2026.05.005_bb0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000499714","article-title":"Clinically relevant anti-neuronal cell surface antibodies in schizophrenia spectrum disorders","volume":"78","author":"Colijn","year":"2019","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2026.05.005_bb0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.2830460233","article-title":"Antiphospholipid antibodies associated with clozapine treatment","volume":"46","author":"Davis","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.schres.2026.05.005_bb0065","first-page":"29","article-title":"Humoral and cellular response against autologous platelets in schizophrenia: clinical and pathophysiological implications","volume":"6","author":"Deckmann","year":"1996","journal-title":"Ital. J. Psychiatry Behav. Sci."},{"key":"10.1016\/j.schres.2026.05.005_bb0075","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1017\/S1461145710001653","article-title":"An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces","volume":"14","author":"Drexhage","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.05.005_bb0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000370077","article-title":"Effect of clozapine and other antipsychotics on the level of platelet-associated autoantibodies in children with schizophrenia: a longitudinal follow-up study","volume":"71","author":"Ebert","year":"2015","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2026.05.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70208","article-title":"Association between levels of the acute phase proteins alpha-1-acid glycoprotein and C-reactive protein and serum concentrations of clozapine: a study of 1106 therapeutic drug monitoring samples","volume":"138","author":"Espnes","year":"2026","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.schres.2026.05.005_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2013.07.029","article-title":"A systematic, quantitative review of blood autoantibodies in schizophrenia","volume":"150","author":"Ezeoke","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.05.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155631","article-title":"Peripheral immune cell populations associated with cognitive deficits and negative symptoms of treatment-resistant schizophrenia","volume":"11","author":"Fernandez-Egea","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2026.05.005_bb0100","article-title":"Low COVID-19 immunoglobulin G titers following vaccination and breakthrough infection in patients taking clozapine","volume":"24","author":"Fournier","year":"2022","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.schres.2026.05.005_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/24725625.2019.1628413","article-title":"Clozapine-induced antineutrophil cytoplasmic antibody-associated vasculitis: a case report","volume":"4","author":"Fujimoto","year":"2020","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"10.1016\/j.schres.2026.05.005_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-016-1177-y","article-title":"Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? A systematic review","volume":"17","author":"Gillespie","year":"2017","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41398-024-03102-8","article-title":"Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts","volume":"14","author":"Gillespie","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/WNF.0000000000000181","article-title":"Encephalitis with antibodies to GluN2B during administration of clozapine","volume":"39","author":"Gon","year":"2016","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.schres.2026.05.005_bb0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbi.2023.10.001","article-title":"Changes in immunoglobulin levels during clozapine treatment in schizophrenia","volume":"115","author":"Griffiths","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.schres.2026.05.005_bb0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0135","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/nprot.2007.297","article-title":"Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data","volume":"2","author":"Hawkins","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.schres.2026.05.005_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12888-024-05689-0","article-title":"Multiple serum anti-glutamate receptor antibody levels in clozapine-treated\/na\u00efve patients with treatment-resistant schizophrenia","volume":"24","author":"He","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-13-154","article-title":"Are healthcare workers\u2019 intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review","volume":"13","author":"Herzog","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.schres.2026.05.005_bb0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0893-133X(98)00006-2","article-title":"Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients","volume":"19","author":"Hinze-Selch","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2026.05.005_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.schres.2026.05.005_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930701619490","article-title":"Autoantibody-mediated disorders of the central nervous system","volume":"41","author":"Irani","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.schres.2026.05.005_bb0170","doi-asserted-by":"crossref","DOI":"10.4103\/jmhhb.jmhhb_24_22","article-title":"Comparative effects of clozapine and risperidone monotherapy on levels of immunoglobulins in patients with schizophrenia \u2013 a 12 weeks\u2019 longitudinal study","volume":"27","author":"Jaswal","year":"2022","journal-title":"J. Ment. Health Hum. Behav."},{"key":"10.1016\/j.schres.2026.05.005_bb0175","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0140-6736(92)91877-B","article-title":"Antimyeloperoxidase antibodies and adverse reactions to clozapine","volume":"339","author":"Jaunkalns","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.schres.2026.05.005_bb0180","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41398-021-01596-0","article-title":"Autoantibody profiles associated with clinical features in psychotic disorders","volume":"11","author":"Jernbom Falk","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.05.005_bb0185","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/cei.12369","article-title":"Calculated globulin (CG) as a screening test for antibody deficiency","volume":"177","author":"Jolles","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.schres.2026.05.005_bb0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3758\/BF03327149","article-title":"Platelets from schizophrenic patients bear autoimmune antibodies that inhibit dopamine uptake","volume":"21","author":"Kessler","year":"1993","journal-title":"Psychobiology"},{"issue":"5","key":"10.1016\/j.schres.2026.05.005_bb0195","first-page":"297","article-title":"Increased use of antibiotics in clozapine-treated patients","volume":"18","author":"Landry","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.05.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1136\/gpsych-2019-100183","article-title":"Clozapine is strongly associated with the risk of pneumonia and inflammation","volume":"33","author":"de Leon","year":"2020","journal-title":"Gen. Psychiatr."},{"issue":"12","key":"10.1016\/j.schres.2026.05.005_bb0205","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/phar.2887","article-title":"A systematic review of clozapine-associated inflammation and related monitoring","volume":"43","author":"Leung","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.schres.2026.05.005_bb0210","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1172\/JCI106283","article-title":"Altered immunoglobulin metabolism in systemic lupus erythematosus and rheumatoid arthritis","volume":"49","author":"Levy","year":"1970","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.schres.2026.05.005_bb0215","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bbi.2024.10.019","article-title":"Immunophenotyping schizophrenia subtypes stratified by antipsychotic response","volume":"123","author":"Li","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.schres.2026.05.005_bb0220","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ajcp\/93.6.771","article-title":"Heterogeneity of laboratory test results for antiphospholipid antibodies in patients treated with chlorpromazine and other phenothiazines","volume":"93","author":"Lillicrap","year":"1990","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.schres.2026.05.005_bb0225","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3923\/ijp.2015.596.603","article-title":"Clozapine regulates cytokines, T-cell subsets and immunoglobulins serum levels in MK-801-evoked schizophrenia rat","volume":"11","author":"Liu","year":"2015","journal-title":"Int. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2026.05.005_bb0230","article-title":"Selective immunoglobulin M deficiency among clozapine-treated patients: a nested case-control study","volume":"17","author":"Lozano","year":"2015","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.schres.2026.05.005_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110450","article-title":"Status of antibiotic residues and detection techniques used in Chinese milk: a systematic review based on cross-sectional surveillance data","volume":"147","author":"Lu","year":"2021","journal-title":"Food Res. Int."},{"issue":"10","key":"10.1016\/j.schres.2026.05.005_bb0240","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jamapsychiatry.2024.1441","article-title":"Pneumonia risk, antipsychotic dosing, and anticholinergic burden in schizophrenia","volume":"81","author":"Luykx","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2026.05.005_bb0245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/156720206776875894","article-title":"Autoantibodies associated with psychiatric disorders","volume":"3","author":"Margutti","year":"2006","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.schres.2026.05.005_bb0250","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.euroneuro.2023.04.003","article-title":"Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis","volume":"73","author":"Martins","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.schres.2026.05.005_bb0255","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archpsyc.1989.01810100098019","article-title":"Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients","volume":"46","author":"McAllister","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0260","first-page":"163","article-title":"Hypogammaglobulinaemia in the United Kingdom: summary report of a Medical Research Council working-party","volume":"1","author":"Medical Research Council","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2026.05.005_bb0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbi.2019.06.043","article-title":"B-cells and schizophrenia: A promising link or a finding lost in translation?","volume":"81","author":"van Mierlo","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"11","key":"10.1016\/j.schres.2026.05.005_bb0270","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00277-020-04215-y","article-title":"Clozapine-induced agranulocytosis","volume":"99","author":"Mijovic","year":"2020","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.schres.2026.05.005_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147601","article-title":"Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis","volume":"11","author":"Modesti","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.schres.2026.05.005_bb0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI106279","article-title":"Metabolic properties of IgG subclasses in man","volume":"49","author":"Morell","year":"1970","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.schres.2026.05.005_bb0285","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.euroneuro.2009.03.002","article-title":"Increased use of antibiotics in patients treated with clozapine","volume":"19","author":"Nielsen","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2026.05.005_bb0290","article-title":"Immune response to vaccination in people with psychotic disorders relative to healthy controls: prospective study of SARS-CoV-2 vaccination","volume":"10","author":"O\u2019Brien","year":"2024","journal-title":"BJPsych Open"},{"issue":"5","key":"10.1016\/j.schres.2026.05.005_bb0295","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jaci.2022.01.025","article-title":"Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a work group report of the AAAAI primary immunodeficiency and altered immune response committees","volume":"149","author":"Otani","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.schres.2026.05.005_bb0300","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fimmu.2014.00117","article-title":"The dopaminergic system in autoimmune diseases","volume":"5","author":"Pacheco","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.schres.2026.05.005_bb0305","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00439-016-1706-2","article-title":"Immunoglobulin G genotypes and the risk of schizophrenia","volume":"135","author":"Pandey","year":"2016","journal-title":"Hum. Genet."},{"issue":"7663","key":"10.1016\/j.schres.2026.05.005_bb0310","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nature23013","article-title":"T(FH)-derived dopamine accelerates productive synapses in germinal centres","volume":"547","author":"Papa","year":"2017","journal-title":"Nature"},{"issue":"9637","key":"10.1016\/j.schres.2026.05.005_bb0315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(08)61199-X","article-title":"Common variable immunodeficiency: a new look at an old disease","volume":"372","author":"Park","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.schres.2026.05.005_bb0320","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1176\/appi.ajp.20230744","article-title":"High burden of ileus and pneumonia in clozapine-treated individuals with schizophrenia: a Finnish 25-year follow-up register study","volume":"181","author":"Partanen","year":"2024","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.05.005_bb0325","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.schres.2014.05.001","article-title":"Meta-analysis of the association between N-methyl-D-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder","volume":"157","author":"Pearlman","year":"2014","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2026.05.005_bb0330","first-page":"1","article-title":"Clozapine is associated with secondary antibody deficiency","volume":"214","author":"Ponsford","year":"2018","journal-title":"Br. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2026.05.005_bb0335","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/jclinpath-2019-206235","article-title":"Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID)","volume":"73","author":"Ponsford","year":"2020","journal-title":"J. Clin. Pathol."},{"issue":"7","key":"10.1016\/j.schres.2026.05.005_bb0340","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.schres.2026.05.005_bb0345","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-020-01733-4","article-title":"Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis","volume":"17","author":"Robichon","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.05.005_bb0350","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","article-title":"Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?","volume":"140","author":"R\u00f8ge","year":"2012","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2026.05.005_bb0355","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/brbi.2001.0648","article-title":"Review of immunological and immunopathological findings in schizophrenia","volume":"15","author":"Rothermundt","year":"2001","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.schres.2026.05.005_bb3000","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1192\/bjp.2021.58","article-title":"Clozapine-induced myocarditis: Electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy","volume":"219","author":"Segev","year":"2021","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.05.005_bb0360","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine induces an acute proinflammatory response that is attenuated by inhibition of inflammasome signaling: implications for idiosyncratic drug-induced agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.schres.2026.05.005_bb0365","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jpsychires.2008.09.009","article-title":"Higher serum clozapine level is associated with increased antiphospholipid antibodies in schizophrenia patients","volume":"43","author":"Shen","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.05.005_bb0370","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1749-6632.1991.tb16980.x","article-title":"Platelet autoantibodies in dementia and schizophrenia: possible implication for mental disorders","volume":"621","author":"Shinitzky","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.schres.2026.05.005_bb0375","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0006-3223(93)90173-B","article-title":"Autoantibodies to DNA in multicase families with schizophrenia","volume":"33","author":"Sirota","year":"1993","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2026.05.005_bb0380","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.05.005_bb0385","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.schres.2026.05.005_bb0390","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.schres.2026.05.005_bb0395","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40263-015-0233-3","article-title":"Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications","volume":"29","author":"Steiner","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2026.05.005_bb0400","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.schres.2026.05.005_bb0405","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1176\/ajp.133.7.772","article-title":"Immunoglobulin levels in psychiatric patients","volume":"133","author":"Strahilevitz","year":"1976","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.05.005_bb0410","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2567.2004.01950.x","article-title":"Divide and conquer: the importance of cell division in regulating B-cell responses","volume":"112","author":"Tangye","year":"2004","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.schres.2026.05.005_bb0415","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1176\/appi.ajp.161.9.1620","article-title":"Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics","volume":"161","author":"Tauscher","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.005_bb0420","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbi.2019.06.017","article-title":"Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia","volume":"81","author":"Tong","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.schres.2026.05.005_bb0425","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/schbul\/sbab003","article-title":"N-methyl-D-aspartate receptor antibody and white matter deficits in schizophrenia treatment-resistance","volume":"47","author":"Tong","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.05.005_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2018.11.004","article-title":"New insights into immune cells cross-talk during IgG4-related disease","volume":"198","author":"Touzani","year":"2019","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.schres.2026.05.005_bb0435","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/schbul\/sbx175","article-title":"Study of novel autoantibodies in schizophrenia","volume":"44","author":"Whelan","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2026.05.005_bb0440","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000222682","article-title":"Clinical and immunological features in IgM deficiency","volume":"150","author":"Yel","year":"2009","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:19:44Z","timestamp":1783509584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426001593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":86,"alternative-id":["S0920996426001593"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.05.005","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review on the effects of clozapine on B-lymphocytes and immunoglobulins","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}